Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
NCT06867393
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
HL-003 tablet Placeco
DRUG:
HL-003 tablet
Sponsor
Shanghai Kechow Pharma, Inc.